JP2022554324A5 - - Google Patents
Info
- Publication number
- JP2022554324A5 JP2022554324A5 JP2022525535A JP2022525535A JP2022554324A5 JP 2022554324 A5 JP2022554324 A5 JP 2022554324A5 JP 2022525535 A JP2022525535 A JP 2022525535A JP 2022525535 A JP2022525535 A JP 2022525535A JP 2022554324 A5 JP2022554324 A5 JP 2022554324A5
- Authority
- JP
- Japan
- Prior art keywords
- prior
- antibody
- cells
- administered
- antibody fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025085318A JP2025134705A (ja) | 2019-10-31 | 2025-05-22 | 抗ｃｄ１９抗体及びガンマデルタｔ細胞を含む抗腫瘍併用療法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19206479 | 2019-10-31 | ||
| EP19206479.8 | 2019-10-31 | ||
| PCT/EP2020/080494 WO2021084063A1 (en) | 2019-10-31 | 2020-10-30 | Anti-tumor combination therapy comprising anti-cd19 antibody and gamma delta t-cells |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025085318A Division JP2025134705A (ja) | 2019-10-31 | 2025-05-22 | 抗ｃｄ１９抗体及びガンマデルタｔ細胞を含む抗腫瘍併用療法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022554324A JP2022554324A (ja) | 2022-12-28 |
| JP2022554324A5 true JP2022554324A5 (https=) | 2023-11-07 |
| JP7688025B2 JP7688025B2 (ja) | 2025-06-03 |
Family
ID=68424789
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022525535A Active JP7688025B2 (ja) | 2019-10-31 | 2020-10-30 | 抗ｃｄ１９抗体及びガンマデルタｔ細胞を含む抗腫瘍併用療法 |
| JP2025085318A Pending JP2025134705A (ja) | 2019-10-31 | 2025-05-22 | 抗ｃｄ１９抗体及びガンマデルタｔ細胞を含む抗腫瘍併用療法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025085318A Pending JP2025134705A (ja) | 2019-10-31 | 2025-05-22 | 抗ｃｄ１９抗体及びガンマデルタｔ細胞を含む抗腫瘍併用療法 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20210130461A1 (https=) |
| EP (2) | EP4706673A2 (https=) |
| JP (2) | JP7688025B2 (https=) |
| KR (1) | KR20220116154A (https=) |
| CN (1) | CN115151565A (https=) |
| AU (1) | AU2020372646A1 (https=) |
| DK (1) | DK4051710T3 (https=) |
| ES (1) | ES3062643T3 (https=) |
| FI (1) | FI4051710T3 (https=) |
| HR (1) | HRP20251630T1 (https=) |
| IL (1) | IL292213A (https=) |
| LT (1) | LT4051710T (https=) |
| MA (1) | MA69251B1 (https=) |
| MD (1) | MD4051710T2 (https=) |
| MX (1) | MX2022005033A (https=) |
| PH (1) | PH12022551009A1 (https=) |
| PL (1) | PL4051710T3 (https=) |
| PT (1) | PT4051710T (https=) |
| RS (1) | RS67602B1 (https=) |
| SI (1) | SI4051710T1 (https=) |
| SM (1) | SMT202600082T1 (https=) |
| TW (1) | TWI883067B (https=) |
| WO (1) | WO2021084063A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2767063C2 (ru) | 2015-08-21 | 2022-03-16 | МорфоСис АГ | Комбинации и их использование |
| US12358983B2 (en) | 2016-10-28 | 2025-07-15 | Incyte Corporation | Combination of anti CD19 antibody with a BCL-2 inhibitor and uses thereof |
| KR20200030337A (ko) | 2018-09-12 | 2020-03-20 | 주식회사 녹십자랩셀 | 종양 치료를 위한 항-cd 19 항체 및 자연살해세포를 포함하는 약학적 조합물 |
| KR102617497B1 (ko) | 2022-09-15 | 2023-12-27 | 주식회사 엘지에너지솔루션 | 음극용 자성 정렬 장치 및 이를 이용한 음극의 제조방법 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
| EP1958962A3 (en) | 1997-06-12 | 2013-05-01 | Novartis International Pharmaceutical Ltd. | Artificial antibody polypeptides |
| US7902338B2 (en) | 2003-07-31 | 2011-03-08 | Immunomedics, Inc. | Anti-CD19 antibodies |
| CA2534639C (en) | 2003-07-31 | 2013-07-30 | Immunomedics, Inc. | Anti-cd19 antibodies |
| CA2611814A1 (en) | 2005-06-20 | 2007-01-04 | Medarex, Inc. | Cd19 antibodies and their uses |
| ES2365046T3 (es) | 2005-12-30 | 2011-09-21 | Merck Patent Gmbh | Anticuerpos anti-cd19 con inmunogenicidad reducida. |
| PL2383297T3 (pl) | 2006-08-14 | 2013-06-28 | Xencor Inc | Zoptymalizowane przeciwciała ukierunkowane na CD19 |
| RU2495882C2 (ru) | 2006-09-08 | 2013-10-20 | Медиммун, Ллк. | Гуманизированные антитела к cd19 и их применение для лечения онкологического, связанного с трансплантацией и аутоиммунного заболевания |
| EP2176298B1 (en) | 2007-05-30 | 2017-11-15 | Xencor, Inc. | Methods and compositions for inhibiting cd32b expressing cells |
| DK2211904T3 (en) | 2007-10-19 | 2016-10-24 | Seattle Genetics Inc | Cd19-binding agents and uses thereof |
| CN102421800A (zh) | 2009-02-23 | 2012-04-18 | 格兰马克药品股份有限公司 | 结合cd19的人源化抗体及其用途 |
| WO2011147834A1 (en) | 2010-05-26 | 2011-12-01 | Roche Glycart Ag | Antibodies against cd19 and uses thereof |
| EP2409712A1 (en) | 2010-07-19 | 2012-01-25 | International-Drug-Development-Biotech | Anti-CD19 antibody having ADCC and CDC functions and improved glycosylation profile |
| EP2409993A1 (en) | 2010-07-19 | 2012-01-25 | International-Drug-Development-Biotech | Anti-CD19 antibody having ADCC function with improved glycosylation profile |
| US8940707B2 (en) | 2010-10-28 | 2015-01-27 | Viropharma Incorporated | Maribavir isomers, compositions, methods of making and methods of using |
| EP2524929A1 (en) | 2011-05-17 | 2012-11-21 | Sanofi | Use of anti-CD19 maytansinoid immunoconjugate antibody for the treatment of CD19+ B-cell malignancies syptoms |
| PT2710123T (pt) | 2011-05-19 | 2017-10-13 | Inst De Medicina Molecular | Linha celular de linfócitos compreendendo células t gama-delta, método de composição e produção resultante dos mesmos |
| AU2015277516A1 (en) * | 2014-06-16 | 2016-12-22 | Xencor, Inc. | Treatment for chronic lymphocytic leukemia (CLL) |
| IL297773B2 (en) | 2014-11-17 | 2024-07-01 | Adicet Bio Inc | Engineered gamma delta t-cells |
| LT3302550T (lt) * | 2015-05-26 | 2019-11-11 | Morphosys Ag | Anti-cd19 antikūno ir brutono tirozino kinazės inhibitoriaus derinys ir jo naudojimas |
| AU2016274633B2 (en) | 2015-06-09 | 2022-04-21 | Gammadelta Therapeutics Ltd | Methods for the production of TCR gamma delta+ T cells |
| WO2017072367A1 (en) | 2015-10-30 | 2017-05-04 | Cancer Research Technology Limited | EXPANSION OF NON-HAEMATOPOIETIC TISSUE-RESIDENT γδ T CELLS AND USES OF THESE CELLS |
| US11299708B2 (en) | 2016-05-12 | 2022-04-12 | Adicet Bio, Inc. | Methods for selective expansion of γδ T-cell populations and compositions thereof |
| WO2018002031A1 (en) | 2016-06-27 | 2018-01-04 | Morphosys Ag | Anti-cd19 antibody formulations |
| WO2018081648A2 (en) * | 2016-10-29 | 2018-05-03 | Genentech, Inc. | Anti-mic antibidies and methods of use |
| GB201707048D0 (en) | 2017-05-03 | 2017-06-14 | King S College London | Expansion of gamma delta cells, compositions, and methods of use thereof |
| TWI687227B (zh) * | 2017-10-03 | 2020-03-11 | 生倍科技股份有限公司 | 用於t細胞免疫療法之組合及其用途 |
-
2020
- 2020-10-30 CN CN202080090109.2A patent/CN115151565A/zh active Pending
- 2020-10-30 PL PL20800121.4T patent/PL4051710T3/pl unknown
- 2020-10-30 JP JP2022525535A patent/JP7688025B2/ja active Active
- 2020-10-30 FI FIEP20800121.4T patent/FI4051710T3/fi active
- 2020-10-30 AU AU2020372646A patent/AU2020372646A1/en active Pending
- 2020-10-30 MX MX2022005033A patent/MX2022005033A/es unknown
- 2020-10-30 SM SM20260082T patent/SMT202600082T1/it unknown
- 2020-10-30 EP EP25217971.8A patent/EP4706673A2/en active Pending
- 2020-10-30 EP EP20800121.4A patent/EP4051710B1/en active Active
- 2020-10-30 PT PT208001214T patent/PT4051710T/pt unknown
- 2020-10-30 KR KR1020227018073A patent/KR20220116154A/ko active Pending
- 2020-10-30 LT LTEPPCT/EP2020/080494T patent/LT4051710T/lt unknown
- 2020-10-30 WO PCT/EP2020/080494 patent/WO2021084063A1/en not_active Ceased
- 2020-10-30 SI SI202030692T patent/SI4051710T1/sl unknown
- 2020-10-30 RS RS20251350A patent/RS67602B1/sr unknown
- 2020-10-30 US US17/084,783 patent/US20210130461A1/en active Pending
- 2020-10-30 IL IL292213A patent/IL292213A/en unknown
- 2020-10-30 MD MDE20220968T patent/MD4051710T2/ro unknown
- 2020-10-30 TW TW109137982A patent/TWI883067B/zh active
- 2020-10-30 ES ES20800121T patent/ES3062643T3/es active Active
- 2020-10-30 DK DK20800121.4T patent/DK4051710T3/da active
- 2020-10-30 MA MA69251A patent/MA69251B1/fr unknown
- 2020-10-30 PH PH1/2022/551009A patent/PH12022551009A1/en unknown
- 2020-10-30 HR HRP20251630TT patent/HRP20251630T1/hr unknown
-
2025
- 2025-05-22 JP JP2025085318A patent/JP2025134705A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022554324A5 (https=) | ||
| WO2013071068A3 (en) | Treatment of hematologic malignancies with an anti-cxcr4 antibody | |
| RU2013113933A (ru) | Антитело к cd38 и леналтдомид или бортезомиб для лечения множественной миеломы и nhl | |
| RU2015110981A (ru) | Комбинации и их применение | |
| JP2017048208A5 (https=) | ||
| JP2013542194A5 (https=) | ||
| RU2014103492A (ru) | Комбинированная терапия антителом к cd19 и азотистым ипритом | |
| IL273841B1 (en) | Antibodies targeting cd137 and methods of use thereof | |
| WO2007087453A3 (en) | Compositions and methods for treating haematological proliferative disorders | |
| MX2019007848A (es) | Anticuerpos anti-pd-1 y usos de los mismos. | |
| PE20130226A1 (es) | Anticuerpos hacia gdf8 humano | |
| WO2005115452A3 (en) | Fcϝriib-specific antibodies and methods of use thereof | |
| NZ600768A (en) | Human antibodies to human angiopoietin-like protein 4 | |
| JP2015530399A5 (https=) | ||
| RU2018107929A (ru) | Комбинации и их использование | |
| JP2012523417A5 (https=) | ||
| RU2017137496A (ru) | Средство для лечения множественной миеломы (ММ) | |
| JP2019519770A5 (https=) | ||
| MX2020008718A (es) | Anticuerpos de union a bcma y usos de los mismos. | |
| MX2024015541A (es) | Anticuerpo anti-cldn18.2, y composicion farmaceutica y uso de la misma | |
| WO2024178202A3 (en) | Anti-cd3 antibodies and methods for their use | |
| JP2025500411A5 (https=) | ||
| FI4051710T3 (fi) | Kasvainta estävä yhdistelmähoito, joka käsittää cd19-vasta-ainetta ja gamma-delta-t-soluja | |
| JP2020500161A5 (https=) | ||
| MX2021008453A (es) | Formulaciones de anticuerpos que se unen a cd137 humano y usos de los mismos. |